BerandaNZYM • VIE
add
Novozymes A/S
Tutup sebelumnya
€55,44
Rentang hari
€55,32 - €55,72
Rentang tahun
€50,12 - €65,04
Kapitalisasi pasar
171,14Â M DKK
Volume Rata-Rata
16,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(EUR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,00Â M | -78,26% |
Biaya operasional | 303,50Â jt | -78,58% |
Laba bersih | 120,95Â jt | -82,67% |
Margin laba bersih | 12,08 | -20,32% |
Penghasilan per saham | — | — |
EBITDA | 369,52Â jt | -69,54% |
Tarif pajak efektif | 26,05% | — |
Neraca
Total aset
Total liabilitas
(EUR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 280,00Â jt | -74,91% |
Total aset | 15,20Â M | -46,48% |
Total liabilitas | 4,02Â M | -71,37% |
Total ekuitas | 11,18 M | — |
Saham yang beredar | 277,90 jt | — |
Harga terhadap nilai buku | 1,38 | — |
Tingkat pengembalian aset | 5,10% | — |
Tingkat pengembalian modal | 5,97% | — |
Arus Kas
Perubahan kas bersih
(EUR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 120,95Â jt | -82,67% |
Kas dari operasi | 245,90Â jt | -78,08% |
Kas dari investasi | -72,40Â jt | 87,99% |
Kas dari pembiayaan | -164,90Â jt | 70,29% |
Perubahan kas bersih | 9,60Â jt | 116,27% |
Arus kas bebas | 195,60Â jt | -72,78% |
Tentang
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
CEO
Didirikan
2000
Situs
Karyawan
10.582